Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Migraine Treatment Market Be Worth By 2029?

In the recent past, there has been a significant growth in the market size of migraine treatments. The market is expected to rise from $3.18 billion in 2024 to $3.45 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%. There are several factors that contributed to this growth in the historic period, such as higher occurrence of migraines, rise in healthcare spending, enhancements in existing drug formulations, expansion in clinical research, and the development of new treatment methods.

In the coming years, the migraine treatment market is projected to witness substantial growth. The market valuation will touch $5.21 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 10.9%. The projected growth during the forecast period can be credited to the heightened awareness and education, the introduction of monoclonal antibodies, growth of emphasis on children’s migraines, the inclusion of non-pharmacological methods, and international efforts toward migraine research. The forecast period will see significant trends such as improved therapeutic methodologies, the rise of wearable devices and digital therapeutics, the boom in telemedicine and remote consultations, patient-focused care structures, the expansion of the generic drug market, and oral CGRP inhibitors.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8126&type=smp

What External And Internal Drivers Are Influencing The Migraine Treatment Market?

The extended interaction with electronic screens is anticipated to fuel the expansion of the market for migraine treatment. This interaction consists of the duration that individuals spend on electronic screens like the ones on smartphones, computers, tablets, and televisions. The elongated interaction with screens is induced by elements like remote working increase, online education, digital amusement, and growing dependence on tech for societal interaction. Treatments for migraines manage symptoms provoked or exacerbated by extended screen usage, including prescribed drugs, lifestyle alterations, and ergonomic practices usage to minimize stress and avoid attacks. For example, reports from the House of Commons Committee, a health agency based in UK Parliament, in May 2024, indicated that in 2021, screen time for children increased by 52% in 2022, and around 25% of children and young people exhibited smartphone consumption habits that were in line with behavioral addiction. Thus, the extension of screen exposure is boosting the expansion of the market for migraine treatments.

What Segmentation Insights Are Provided In The Migraine Treatment Market Research?

The migraine treatmentmarket covered in this report is segmented –

1) By Types: Episodic; Migraine With Aura; Chronic; Other Types

2) By Treatment: Acute Or Abortive Treatment; Preventive Or prophylactic Treatment; Non-Pharmacological Therapies And Devices

3) By End-User: Hospitals; Clinics; Homecare; Other End-users

Subsegments:

1) By Episodic: Frequent Episodic Migraine; Infrequent Episodic Migraine

2) By Migraine With Aura: Visual Aura; Sensory Aura; Speech Or Language Aura

3) By Chronic: Chronic Migraine Without Aura; Chronic Migraine With Aura

4) By Other Types: Hemiplegic Migraine; Retinal Migraine; Menstrual Migraine; Other Specific Types

Which Market Trends Are Expected To Define The Future Of The Migraine Treatment Market?

In the migraine treatment market, product innovations are emerging as a crucial trend. Established companies in the sector are coming up with innovative solutions like liquid formulations to maintain their market dominance. For example, BioDelivery Sciences International (BDSI), a pharmaceutical company based in the United States, brought Elyxyb (celecoxib oral solution) to the market in January 2022. This solution offers acute treatment for adult migraine sufferers, regardless of whether they experience aura. The liquid formulation ensures quick absorption in the small intestine and offers relief at a faster pace than conventional tablets. This is particularly suitable for individuals who experience nausea or vomiting due to migraines, as it doesn’t require waiting for a pill to dissolve. Elyxyb, being the only FDA-approved ready-to-use oral solution for migraines, serves as a more bearable and effective treatment option to manage the sharp, severe pain associated with migraines.

Who Are The Leading Companies Driving The Migraine Treatment Market?

Major companies operating in the migraine treatment market are Pfizer Inc., Eli Lilly and Company, Amgen Inc., GlaxoSmithKline PLC, Novartis AG, Bayer AG, Allergan PLC, Abbott Laboratories, Allodynic Therapeutics LLC, AOBiome LLC, AstraZeneca PLC, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Limited, Impel Pharmaceuticals Inc., AbbVie Inc., Alder BioPharmaceuticals Inc., Astellas Pharma Inc., Biohaven Pharmaceutical Holding Company Ltd., Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Endo International PLC, Impax Laboratories Inc., Johnson & Johnson Inc., Lannett Company Inc., Lupin Limited, Merck & Co. Inc., Mylan N.V.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Migraine Treatment Market?

North America was the largest region in the migraine treatment market in 2024. The regions covered in the migraine treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=8126&type=smp

Browse Through More Reports Similar to the Global Migraine Treatment Market 2025, By The Business Research Company

Ent Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ent-devices-global-market-report

Nasal Splints Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nasal-splints-global-market-report

Cough And Cold Preparations Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cough-and-cold-preparations-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model